391 related articles for article (PubMed ID: 12514108)
1. Inhibition of tumor angiogenesis by cannabinoids.
Blázquez C; Casanova ML; Planas A; Gómez Del Pulgar T; Villanueva C; Fernández-Aceñero MJ; Aragonés J; Huffman JW; Jorcano JL; Guzmán M
FASEB J; 2003 Mar; 17(3):529-31. PubMed ID: 12514108
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors.
Casanova ML; Blázquez C; Martínez-Palacio J; Villanueva C; Fernández-Aceñero MJ; Huffman JW; Jorcano JL; Guzmán M
J Clin Invest; 2003 Jan; 111(1):43-50. PubMed ID: 12511587
[TBL] [Abstract][Full Text] [Related]
3. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.
Vajkoczy P; Farhadi M; Gaumann A; Heidenreich R; Erber R; Wunder A; Tonn JC; Menger MD; Breier G
J Clin Invest; 2002 Mar; 109(6):777-85. PubMed ID: 11901186
[TBL] [Abstract][Full Text] [Related]
4. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors.
Yamakawa M; Liu LX; Date T; Belanger AJ; Vincent KA; Akita GY; Kuriyama T; Cheng SH; Gregory RJ; Jiang C
Circ Res; 2003 Oct; 93(7):664-73. PubMed ID: 12958144
[TBL] [Abstract][Full Text] [Related]
6. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth.
Fahmy RG; Dass CR; Sun LQ; Chesterman CN; Khachigian LM
Nat Med; 2003 Aug; 9(8):1026-32. PubMed ID: 12872165
[TBL] [Abstract][Full Text] [Related]
7. Biomedical significance of endothelial cell specific growth factor, angiopoietin.
Koh GY; Kim I; Kwak HJ; Yun MJ; Leem JC
Exp Mol Med; 2002 Mar; 34(1):1-11. PubMed ID: 11989972
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the angiogenesis response through Ha-ras control, placenta growth factor, and angiopoietin expression in mouse skin carcinogenesis.
Larcher F; Franco M; Bolontrade M; Rodriguez-Puebla M; Casanova L; Navarro M; Yancopoulos G; Jorcano JL; Conti CJ
Mol Carcinog; 2003 Jun; 37(2):83-90. PubMed ID: 12766907
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor and angiopoietin 2 expression in laser-treated choroidal neovascular membranes.
Otani A; Takagi H; Oh H; Koyama S; Sugita G; Ogura Y
Retina; 2003 Jun; 23(3):402-4. PubMed ID: 12824844
[No Abstract] [Full Text] [Related]
10. Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumors: potential relationship to post-therapy tumor angiogenesis and recurrence.
Taylor AP; Rodriguez M; Adams K; Goldenberg DM; Blumenthal RD
Int J Cancer; 2003 Jun; 105(2):158-64. PubMed ID: 12673673
[TBL] [Abstract][Full Text] [Related]
11. Infectious angiogenesis: Bartonella bacilliformis infection results in endothelial production of angiopoetin-2 and epidermal production of vascular endothelial growth factor.
Cerimele F; Brown LF; Bravo F; Ihler GM; Kouadio P; Arbiser JL
Am J Pathol; 2003 Oct; 163(4):1321-7. PubMed ID: 14507641
[TBL] [Abstract][Full Text] [Related]
12. A novel hypoxia-dependent 2-nitroimidazole KIN-841 inhibits tumour-specific angiogenesis by blocking production of angiogenic factors.
Shimamura M; Nagasawa H; Ashino H; Yamamoto Y; Hazato T; Uto Y; Hori H; Inayama S
Br J Cancer; 2003 Jan; 88(2):307-13. PubMed ID: 12610518
[TBL] [Abstract][Full Text] [Related]
13. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features.
Bunone G; Vigneri P; Mariani L; Butó S; Collini P; Pilotti S; Pierotti MA; Bongarzone I
Am J Pathol; 1999 Dec; 155(6):1967-76. PubMed ID: 10595926
[TBL] [Abstract][Full Text] [Related]
14. Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin.
Sarlos S; Rizkalla B; Moravski CJ; Cao Z; Cooper ME; Wilkinson-Berka JL
Am J Pathol; 2003 Sep; 163(3):879-87. PubMed ID: 12937129
[TBL] [Abstract][Full Text] [Related]
15. Temporal profile of angiogenesis and expression of related genes in the brain after ischemia.
Hayashi T; Noshita N; Sugawara T; Chan PH
J Cereb Blood Flow Metab; 2003 Feb; 23(2):166-80. PubMed ID: 12571448
[TBL] [Abstract][Full Text] [Related]
16. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.
Giavazzi R; Sennino B; Coltrini D; Garofalo A; Dossi R; Ronca R; Tosatti MP; Presta M
Am J Pathol; 2003 Jun; 162(6):1913-26. PubMed ID: 12759248
[TBL] [Abstract][Full Text] [Related]
17. Extracellular matrix-bound vascular endothelial growth factor promotes endothelial cell adhesion, migration, and survival through integrin ligation.
Hutchings H; Ortega N; Plouët J
FASEB J; 2003 Aug; 17(11):1520-2. PubMed ID: 12709411
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis in epithelian ovarian cancer.
Bamberger ES; Perrett CW
Mol Pathol; 2002 Dec; 55(6):348-59. PubMed ID: 12456770
[TBL] [Abstract][Full Text] [Related]
19. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
Hagedorn M; Zilberberg L; Wilting J; Canron X; Carrabba G; Giussani C; Pluderi M; Bello L; Bikfalvi A
Cancer Res; 2002 Dec; 62(23):6884-90. PubMed ID: 12460903
[TBL] [Abstract][Full Text] [Related]
20. Incipient angiogenesis.
Folkman J
J Natl Cancer Inst; 2000 Jan; 92(2):94-5. PubMed ID: 10639502
[No Abstract] [Full Text] [Related]
[Next] [New Search]
